Related Experiment Video
Updated: Jul 23, 2025
Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures
Published on: December 22, 2014
Txnip Gene Therapy of Retinitis Pigmentosa Improves Cone Health
1Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. yunlu_xue@hms.harvard.edu.
Abstract:
Retinitis pigmentosa (RP) is a hereditary retinal degenerative disease that can lead to blindness. In RP, rod photoreceptors die first, followed by cone photoreceptors death due to unknown mechanisms. However, one clue for cone death concerns their metabolism. Early changes suggest that they do not have enough glucose, which normally fuels their metabolism. We sought to design adeno-associated virus (AAV)-based gene therapy to address their metabolic challenges and found that overexpressing Txnip is an effective gene therapy that extends cone survival and vision in three strains of RP mice. The Txnip-mediated rescue was found to be dependent upon lactate dehydrogenase b (Ldhb), which is required for lactate catabolism. Txnip also was found to improve mitochondrial health. Herein, we propose a model in which Txnip shifts cones from their normal reliance on glucose to enhanced utilization of lactate to benefit cones in a condition where the glucose supply is limiting.
Insights
Gene therapy using Txnip successfully extended cone survival and vision in retinitis pigmentosa (RP) mouse models. This approach enhances lactate utilization, offering a new strategy for treating this blinding retinal disease.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Retinitis pigmentosa (RP) is an inherited condition causing progressive vision loss and blindness.
- Cone photoreceptor degeneration in RP is linked to metabolic dysfunction, specifically insufficient glucose supply.
- Current treatments for RP are limited, necessitating novel therapeutic strategies.
Purpose of the Study:
- To develop an adeno-associated virus (AAV)-based gene therapy for RP targeting cone photoreceptor metabolism.
- To investigate the role of Txnip in rescuing cone photoreceptors in RP models.
- To elucidate the metabolic mechanisms underlying Txnip-mediated cone protection.
Main Methods:
- Adeno-associated virus (AAV)-based gene therapy vector construction for Txnip overexpression.
- In vivo studies utilizing three distinct strains of RP mouse models.
- Assessment of cone photoreceptor survival, vision function, and metabolic parameters.
Main Results:
- Overexpression of Txnip via AAV gene therapy significantly extended cone photoreceptor survival and preserved vision in RP mice.
- The therapeutic effect of Txnip was dependent on lactate dehydrogenase b (Ldhb), indicating a role in lactate metabolism.
- Txnip treatment improved mitochondrial health and shifted cone metabolism towards enhanced lactate utilization.
Conclusions:
- Txnip-based gene therapy represents a promising strategy for treating retinitis pigmentosa by addressing cone photoreceptor metabolic deficits.
- The findings suggest a model where Txnip promotes cone survival by facilitating lactate catabolism when glucose is limited.
- This research opens new avenues for developing metabolic interventions for inherited retinal diseases.
More Related Videos
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
08:04Cone-Enriched Cultures from the Retina of Chicken Embryos to Study Rod to Cone Cellular Interactions
Published on: March 20, 2021
